NSD5Efficacité et Sécurité du Dextrose 5% Intraveineux vs Sérum Physiologique dans l'Hémodialyse pour les Patients atteints d'IRCT - Contrôle de la Pression Artérielle Systolique

This clinical trial is a comparison study between two solutions used in a procedure called 'wash back' during hemodialysis for patients with end stage renal failure (ESRF). The study aims to find out if a sugar solution called intravenous dextrose 5% is more effective than the standard care solution, normal saline (0.9% sodium chloride), in controlling systolic blood pressure over a 3-month period. This research is important as it could potentially improve the management of blood pressure in patients undergoing regular hemodialysis, addressing a common challenge in ESRF care. During the trial, participants receive either the dextrose solution or normal saline during their dialysis sessions. The main goal is to measure how much the systolic blood pressure reduces after the intervention compared to the baseline. Additionally, the study monitors changes in body weight, thirst level, and body fluid volume. These measurements help evaluate the overall safety and effectiveness of using dextrose solution in the wash back procedure.